Table 2.
ABI |
faPWV |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
β | Std. β | 95% CI | P Value | β | Std. β | 95% CI | P Value | |||
Model 1 | ||||||||||
Age (years) | −0.004 | −0.139 | −0.167 | −0.110 | <0.001 | 0.011 | 0.030 | 0.001 | 0.059 | 0.045 |
Male Sex | 0.042 | 0.156 | 0.125 | 0.186 | <0.001 | 0.109 | 0.028 | −0.004 | 0.059 | 0.083 |
Systolic blood pressure (mm Hg) | 0.000 | 0.005 | −0.023 | 0.033 | 0.724 | 0.023 | 0.208 | 0.179 | 0.237 | <0.001 |
High-density lipoproteins (mg/dL) | 0.001 | 0.067 | 0.034 | 0.100 | <0.001 | 0.009 | 0.066 | 0.031 | 0.100 | <0.001 |
Total Cholesterol (mg/dL) | 0.000 | −0.072 | −0.105 | −0.040 | <0.001 | 0.000 | 0.003 | −0.031 | 0.036 | 0.869 |
Smoker | −0.099 | −0.173 | −0.200 | −0.145 | <0.001 | −0.308 | −0.037 | −0.066 | −0.008 | 0.011 |
Diabetes | −0.009 | −0.030 | −0.060 | −0.002 | 0.039 | −0.099 | −0.023 | −0.053 | 0.007 | 0.128 |
Overall Model Fit | mR2 = .073 | cR2 = .189 | mR2 = .058 | cR2 = .103 | ||||||
Final Model * | ||||||||||
Age (years) | −0.004 | −0.138 | −0.166 | −0.110 | <0.001 | 0.012 | 0.030 | 0.001 | 0.059 | 0.042 |
Male sex | 0.042 | 0.155 | 0.125 | 0.186 | <0.001 | 0.106 | 0.027 | −0.004 | 0.058 | 0.089 |
Systolic blood pressure (mm Hg) | 0.023 | 0.208 | 0.179 | 0.237 | <0.001 | |||||
High-density lipoproteins (mg/dL) | 0.001 | 0.067 | 0.034 | 0.100 | <0.001 | 0.010 | 0.071 | 0.039 | 0.102 | <0.001 |
Total Cholesterol (mg/dL) | 0.000 | −0.072 | −0.104 | −0.040 | <0.001 | |||||
Smoker | −0.099 | −0.173 | −0.201 | −0.145 | <0.001 | −0.305 | −0.037 | −0.066 | −0.008 | 0.012 |
Diabetes | −0.009 | −0.030 | −0.060 | −0.002 | 0.039 | |||||
Overall Model Fit | mR2 = −0.073 | cR2 = .189 | mR2 = .058 | cR2 = .103 |
Abbreviations: β, beta coefficient; CI, confidence interval; std. β, standardized beta coefficient; mR2, marginal R squared coefficient; cR2, conditional R squared coefficient.
Adjustments: antihypertensive medication, race/field center